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ABSTRACT 
The eyes, the trigeminal ganglia and the superior 
cervical ganglia of CD-1 mice were studied as a model for 
recurrent herpetic infections. Animals were corneally infected 
with Type 1 herpes simplex virus (HSV-1). During the period 
of acute infection, both gnaglionic tissues were demonstrated 
to have almost 100 % infection *ith herpes virus. Following 
recovery from the acute infection, HSV was shown to be latent 
in both ganglionic tissues; the HSV could be demonstrated in 
over 75% of trigeminal ganglia and approximately 20 % of 
superior cervical ganglia by exp la ntation of gnaglia. During 
t he latent phase, spontaneous reactivation in both ocular 
and ganglionic t issues were uncommon in our animals. Different 
stimuli, including fever ~ thermal burn, mechanical trauma, 
treatment with cyclophospham i de (CPA), an immunosuppressant, 
and physical stress were employed in attempts to induce 
recurrent infection. Daily cultures of eye swabbings and 
cultures of homogenates of the ganglia were used to sutdy 
effects of these stimuli on virus reactivation. A low 
incidence of reactivation (approximately 10%) was demonstrated 
in eyes and trigeminal gnaglia following CPA trea t men~ of 
these mice. The other stimuli apparently p~oduced no reactiva-
tion of infection in our animals. This mouse eye model may 
still prove to be useful for studying the mechaniams of viral 
, . 
. .... 
V 
latency and reactivation in herpe ti c infection, and thus 
war rants investigatio n . 
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INTRODUCTION 
The three phases of herpetic infection (acute, latent 
and recurrent) have been well documented. During the last 
ten years, various investigators (Stevens and Cook, 1971; 
Baringer et al, 1973) have demonstrated the presence of latent 
virus in sensory ganglia of infected hosts, by explantation 
of these ganglia. However, the mec han ism , of viral late n cy 
and its reactivation in the host are still not clear. Thus, 
an animal model for investigating HSV latency and recurrence 
would be useful. 
Various animals, including rabbits, guinea pigs, and 
mice, have been used for investigating these three phases of 
herpetic infection. During the acute phase, virus has been 
demonstrated to be present in different parts of the body in 
most infected animals (Cook and Stevens, 1976; Knotts et al, 
1974). During the latent phase, the virus was found in 
explants of neural ganglia in most latently infected animals 
(Stevens et al, 1972; Walz et al, 1974; Hill et al, 1975). 
During the recurrent phase infectious virus can be recovered 
from both the ganglia and the previously infected tissue 
(skin or mucosa) of some animals. In addition, ppontaneous 
reactivation of the virus can also occur (Laibson and Kibrick, 
1969; Hill et al,1978; Scriba, 1975). A mouse model is 
especially suitable for examining these phenomena since large 
numbers of animals can be studied at the same time and p with 
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proper care, for a long period of time. The specific amis 
of this thesis research were: 
( 1) To demonstrate that ocular infection of the mouse 
with HSV induces a latent infection in both 
trigeminal and superior cervical ganglia. 
(2) To examine the cha r acteristics of herpetic infection 
in ocular tissues during the three phases of infec-
tion by cultures of eye swabbings and by examina-
tion of corneal lesions. 
(J) To determine the frequency of spontaneous reactiva-
tion in mice with the latent HSV infection. 
(4) To produce recurrent infections by various methods 
in the latently infected mice. 
(5) To study the relationship between viral reactiva-
tion in eyes and viral reactivation in the ganglia. 
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LITERATURE REVIEW 
A. HISTORY 
B. MORPHOLOGY 
C. EPIDEMIOLOGY AND CLINICAL MANIFESTATION OF HERPES VIRUS 
INFECTIONS 
D. HSV INFECTIONS AND NERVOUS TISSUE 
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1. Evidence for Neural Site of Latency in Human HSV Infection. 
a. Neurosurgical observations. 
b. Observations on neuralgic pain. 
c. Studies of skin trausplantatto ·n. 
d. Explantation studies of skin and mucosa. 
e. Studies on suscept of epithelial cells to HSV infection. 
f. Studies on dermatomal distribution of lesions. 
g. Studies on explanted ganglia. 
2. Pathways of HSV Spread to the N.ervous System i n Animals. 
a. Evidence for neural pathway by Schwann cells. 
b. Evidence for neural pathway by axon. 
c. Evidence ' for other pathways. 
J. Ev idence f or Latent Infect i on of Ganglia with HSV. 
4. Evidence that Neurons are the Ce lls Involved in HSV 
Ganglionic Infection. 
a. HSV recovered only from explants of ganglia, not from 
nerve or root. 
b. Complete virons present only in the neuron. 
c. Reactivated viruses , d~tebtSd ~ihiti~lly .. o~ly ~in · the neuvon. 
E. RECURRENT HSV INFECTION IN HUMAN AND ANIMALS 
Stimuli for precipitation of Recurrent Herpes Viruses 
1. Manipulation of the Nerve. 
2. Trauma. 
J. Fever. 
4. Sunlight, UV-light and Radiation. 
5. Emotional Stress. 
6. Epinephrine. 
7. Bacterial Infection. 
8. Local Arthus Reaction and Anaphylactic Shock. 
9. Immunosuppression. 
F. CELLULAR MECHANISMS OF LATENT AND RECURRENT HSV; HYPOTHESIS: 
1. Characteristics of Cells Harboring Latent Infection. 
2. Role of the Immune System in HSV Infection. 
J. Neuronal Hypothesis of HSV Recurrence. 
4. Ganglionic Trigger vs Skin Trigger Hypothesis. 
5. Dynamic vs Static State Hypothesis. 
6. One-way vs Round-trip Hypothesis. 
7. Immune Modulation vs Immune Elimination Hypothesis. 
8. Other Postulations: 
a. Lack of "Transcriptase" in physiological state of neuron. 
b. Double binding of IgG to the infected cells. 
LITERATURE REVIEW 
A. HISTORY 
Disease due to herpes simplex virus (HSV) has been known 
for centuries. Herpes simplex, cold sores on the lips, is 
to our knowledge the only virus disease mentioned by 
Shakespeare (Romeo and u l i et I, iv, 75) but it ca n be traced 
much further back, certainly to t he common a n cesto r of man 
and the old world monkeys somewhere i n t he Oli g ocene and 
perhaps to the earliest mammals in the Cretaccus p ri od 
(Burnet and White, 1972). 
The term herpes is derived from a Greek verb meanin g t o 
creep or spread (Ship, 1974). Early wr it ers used the word 
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in a much wider sen se than we d o today, and it is q e s t i onable 
whether the lesions desc ribed by ar ly sources su ch as the 
Prorrhetics, the Aphorisms and Epidermics of the Hippocra t ic 
wr iting include herpes zoster, though it is conceivable that 
som e of the cases of "ardent fever, phrensy, aphthous affections 
of the mouth ... " might have been due to primary herpetic 
gingivo-stomatitis(Juel-Jensen and Maccallum, 1972). 
Around A.D. 100, Herodotus, a Roman Ph ysi cian, described 
"the herpetic eruptions which appeared about the mouth at 
the crisis of simple fevers" (herpes febrilis). Sixteen 
centries later, in France, As t ruc recorded genital herpes in 
both men and women (herpes genitalis). Although the term 
herpes had originally been applied to various spreading 
cutaneous lesions, by the nineteenth century its defin it ion 
was becoming more limited to the description of vesicu l a r 
eruptions (Nahmias and Kohl, 1976). Further differen t iation 
of these eruptions was a id e d by the subsequent discoveries 
of four German or Aust ria n physicians. Unna, in the late 
nineteenth century, distinguished between infections caused 
by members of the pox group and the herpes group on t he basis 
of cytopathological features. The differentiation between 
herpes zoster and herpes f ebrilis (simplex) was made possible 
by Gruter's demonstration (1913) that only herpes fe brilis 
could be transmitted to the rabbit cornea. A few years later, 
Lipschutz (1921) proposed that herpes febrilis and herpes 
genitalis "although b iologically rela te d ar e etiologically 
different (Na hmias and Kohl, 1976). It was not until 40 years 
later t hat the demonstration of the existence of two antigenic 
types of herpes simplex virus by Schneweis (1961) provided 
the means f or Lipschutz's concepts to be confirmed by workers . 
in the United States (Nahmias a n d Dowdle, 1968). 
B. MORPHOLOGY 
HSV has an estimated diameter of 100 to 180 nm Electron 
microscopic studies by Wildy and associates in 1960 revealed 
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that the virus particle (virion) consists of a central core, 
about 75 nm in diameter, containing double-stranded DNA and 
a protein coat (capsid), about 100 nm in diameter, with the 
symmetry of an icosahedron (Twenty-sided figure). 
is composed of 162 capsomeres (Wildy et al, 1960). 
The capsid 
The 
virions are frequently noted to have lipoidal envelopes which 
are derived from the host cell membranes and which surround 
the capsids (Scott and Todumaru, 1964). Herpesvirus particles 
with envelopes, as well as those without, appear to be infective 
(Lur i a and Darnell, 1968). 
HSV is readily transmitted to a variety of an i mals, 
including rabbits mice, guinea pigs, cotton rats, and hamsters. 
Th e chorioallantoic membrane of the chick embryo and a variety 
of cells grown in tissue culture also support the multiplica-
tion of the virus including: human kidney, human carcinoma 
(HeLa), and rabbit kidney. 
Two antigenic types of HSV have been identified (Nahmias 
and Dowdle, 1968; Nahmias et al, 1971). HSV type 1 has been 
associated chiefly with infections of the mout h, lips, eyes 
and central nervous system in adults; type 2 has been most 
commonly associated with genital and neonatal infections 
(Krugman, Ward and Katz, 1977). The two types of virus are 
antigenically distinct, but closely related and share common 
antigens (Plummer, 1973). 
6 
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C. E.PIDEMIOLOGY AND CLINICAL MANIFESTATION OF HERPES VIRUS INFECT I ONS 
The virus most commonly infects ectodermally derived 
tissue (skin, mucous membrane, nervous tissue) and the 
characteristic vesicle may be apparent at the time of primary 
infection or the primary infection may be sub-clinical and 
ev idenced only by a rising titer of neutralizing anti b odi es . 
Th e initiation of infection probably oc curs wi t h th e pene tr a-
tion of the mucous membranes by the virus. The virus do e s 
not penetrate intact healthy skin. However, diseased or broken 
s k in is susceptible to the virus and there are a number of 
clinical entities associated with infection of sites other 
than the genitalia, oral cavity or eyes. Among these is 
'!herpetic whi tlo w" which is an infection of the fingers. This 
desease represents the entry of the virus through a minor 
abrasion of the finger tips and is an occupational hazard for 
nurses, physicians and dentists (Muller and Hermann, 1970; 
and Rosatto et al, 1970). The chief mode of transmission in 
humans is through oral or sexual contact (Kibrick and Gooding, 
1966), and the feces may less commonly be a source of 
contagion. Transmission to the fetus and the newborn may 
occur by maternal viremic-transplacental spread or by the 
ascending cervical amniotic route (Hanshaw and Dudgeon, 1978). 
Infections are more common a mong children of the lower 
socioeconomic classes than among children of the upper 
socioeconomic classes, which is probably a reflection of the 
different sanitation bet ween those groups (Buddingh et al, 
1953; and Smit et al, 1967). In the former setting nearly 
100 % of the population experiences an initial infection by 
the virus by the time the individuals reach adulthood. 
However, among upper socioeconomic classes as many as 40 % 
of young adults will not have been infected. 
There was a curious finding at the social level. I n 
1938-9 in Melbourne, 95% of underprivileged children attending 
a public hospital had serologic evidence of infection by 
herpes simplex, whereas those from comfortable middle-class 
homes showed a much lower proportion. Eight years later, 
patients at Children :'s Hospital sho wed on l y 57% positive. 
Rightly or wrongly, they regard ed and still regard this as 
an indication of the way knowledge of the value of care and 
cleanliness is spreading through the community (Burnet and 
White, 1972). There could be worse indices of the level of 
civilization than the proportion of people who are not 
carriers of herpes. 
The virus produces a variety of lesions in the human 
host. The incubation period for the primary infection is 
from 2 to 12 days. In neonates and infants, primary infection 
may be manifested by a generalized systemic illness or by a 
severe and often fatal encephalitis. In patients with 
eczema, the skin may show lesions superimposed on the eczematous 
areas, eczema herpeticum. The mucous membranes are common 
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sites for HSV infection, and the virus may cause not only a 
gingivostomatitis, but also a vulvo vag initis. Herpetic 
gingivostomatitis is a relatively common clinical condition 
among children between one to five years old. Acute herpetic 
gingivostomatitis may also occur in adults (Silverman and 
Beumer III, 1973). Both HSV-1 and HSV-2 may be the cause of 
herpetic gingivostomatitis. The virus may also invade the 
eyes, producing an herpetic keratoconjunctivitis (Robbins 
and Ewing, 1967). This particular infection causes more 
vision reduction and blindness than any other corneal disease 
in North America (Duggan, 1962). 
After the primary infection clears, the virus becomes 
latent. It is generally agreed that the infections of the 
skin, mucous membranes, and eyes can recur at any point in 
life, causing new lesions in the previously infected dermatomes. 
Rrcurrence is not necessarily preceded by exposure to HSV, 
and is understood to be a manifestation of reactivation of 
a latent viral disease. For example, recurrent herpes simplex 
infections of the lips (or perioral area) is a very common 
herpes simplex virus recurrent manifestation and it has been 
estimated to occur in 20 to 40% of the population (Young et al, 
1976; and Embit et al, 1975). Recurrences may also follow 
exogenous infection. 
Recurrence occurs in those individuals who have circulating 
antibodies, but the reappearance of the virus is not necessarily 
accompanied by disease. Kaufmann et al (1967 & 1968) has 
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found that HSV cancommonly be found in tears and saliva of 
patients in the absence of lesion. Similar findings that 
HSV may be present in saliva and tears of clinically normal 
human have been reported by oth ers (Dauglas and Couch, 19 70; 
Sprauance e t al,1977; Bader and Crumpacker, 1978). Low 
grade anti-HSV activity in fluids from these tissues has also 
been demonstrated (Douglas and Couch, 1970; Mankad et al, 
1973; Heineman and Greenberg, 1980; Hochman e t al, 19 81; 
Centifanto et al, 1970; Gyselink et al, 19 78). 
The pathogensis of herpes simplex virus in man is 
summarized as follows. 
HSV-1 (mou th, 
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Susceptible host 
( no Ab) 
eyes, etc.) 
~-:~-------Virus 
I 
HSV-2 
\ 
( g_eni tals, 
ne wborns, etc, 
Primary 
_I Infection ➔ Reinfection •<--Virus Reactivation ' (C or S disease) 
Disease 
(uncommon) 
$ubclinical 
infect i on 
( usual) 
Virus localized 
in corresponding 
sensory gnaglion 
Carrier 
., .(ab & virus 
present) 
Excitants 
(feve r~ URI, 
stress, etc.) 
D. HSV INFECTION AND THE NERVOUS TISSUE 
1. Evidence f or Neural Site of La t en cy in Human HSV Infection: 
A ne ur al site of latency in human HSV infection 
has been sugges t ed by a number of studies that show the 
followin g : 
a. Mutiple ne u rosur g ical pro c edures ha ve demon s t r ated that 
st i mul ati on of the trigeminal ganglion duri ng surgery 
produc e s recurrence of fa cial herpes in man (Cushing, 
1904; Sa r ton and Kibourne, 1952; Carton, 1953; Ellison 
et al, 1959; Pazin et al, 1978) 
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b. Par e s t hesias and neuraligic pain preceding an outbreak 
of r ecu rr ent HSV infection in man suggest that the 
ner v ous system may be involved (Baringer, 1975; Constatine 
et al, 1968; Layzer and Conant, 197~). 
c. When skin from areas of recurr ent herpes lesions was 
transplanted to oth er par t s of the b ody, recurrence of 
HSV was not observed in the transplanted skin (Stalder 
and Zurokzoglu, 1936). However, recurrence was seen 
near the original site in the adjacent skin. Subepidermal 
bulla, a new post-surgical form of recurrent HSV at a 
site -hich had been transversely excised has been 
described (Shelly and Wood, 1979). This certainly 
suggests that recurrence does not depend on the presence 
of latent herpsvirus in the skin itself. 
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d. None of the cultured skin or mucosa from sites of recurrent 
HSV between episodes of recurrence was positive for HSV 
(Rustigian et al, 1966; Smith et al, 1977; Sabin, 1975). 
-- --
e. There was no difference in susceptibility of epith e lial 
cells to herpes simplex virus between herpes la b ialis 
cases and history free cases (Spru a uce and Chow, 1980). 
f. Recurrent peripheral lesions of HSV r emain localized to 
the dermatome where the initial infection recurred (Kibrick 
and Gooding, 1966). 
g. Se v eral workers have successfully recovered HSV by co-
cul t ivation from human trigememipal _gangiia (Bastian, 1972; 
Baringer and Swoveland, 1973; Baringer et _al, 1974; 
Plummer, 1973; Rodda, 1973). Virus has also been recovered 
from various other human ga ng lia, such as thoracic, sacral 
(Forghani, 1977), superior cervical and vagus ganglia 
(Warren et al, 1978). Virus was not demonstrated in 
adjacent nerve roots or sensory roots, even though these 
tissues were shown to be sensitive to infection when 
delibera t ely infected afterward. Baringer (1974) also 
demonstrated simultaneous infection of type 1 in the 
trigeminal and type 2 in the sacral ganglia in one 
individual. 
2. Pathways of HSV Spread to the Nervous System in Animals: 
The idea that herpes simplex v iruses travel in nerves 
was suggested as early as 1923 by Goodpasture and Teague. 
In their studies, animals inoculated via the cornea subsequently 
developed grossly apparent lesions in the trigeminal tract 
of the pons and medulla on the ipsilateral side, but no 
l e sions were observed in the optic tract. Goodpasture (1 925) 
also inoculated rabbits in several sites and was abl e t o 
demonstrated CNS lesion in areas corresponding to the central 
t ermination of not only other senso r y nerves, but also motor 
and sympathetic nerves. Furthermore, Wildy (1967) showed that 
the infection traveled centripetally to and through the CNS, 
but such passage did not occur when the nerve had been sectioned 
before inoculation. 
With the completion of these experiments, the relationship 
between peripheral infection and central nerve system disease 
was fully established, and a strong argument for transmission 
in nerve trunks was made o 
a. Evidence for neural pathway by Schwann cells: 
In 1964, Johnson showed that footpad inoculation of 
mice was followed by an advancing, centripetal infection 
of endoneural cells in the sciatic nerve. In his studies, 
the fluorescent antibody stain was seen in endoneural and 
Schwann cells within the nerve, but none was seen within 
the axon. 
Subsequently, Rabin et al (1968) confirmed Johnson's 
experiments by noting herpes simplex virus within Schwann 
cells using electron microscopy. A similar observation 
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was made by Constatine, Francis, and Mason (1971); they 
suggested that the downward travel of virus is also via the 
Schwann cells. The general concept thus developed that the 
predominant mode of travel of herpe simplex virus within the 
nerves is via the Schwann and endon ·eural cells and · eventu al ly 
virus be came l a t ent wi th i gan glian cells. Th e virus also 
tr avels downward to the target cells through Schwann cells 
ai t er reactivation. 
b. Evidenc~ for , neural pathway by axon: 
A different opinion has developed in recent years . . 
Serial obse r vations of rabbit trigeminal ganglia after corneal 
infection (Baringer and Griffith, 1970) indicated that in all 
cases the ganglian cells contained viral inclusions before 
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the Schwarm or satellite cells and that satellite cell infec-
tion was not seen in the absence of infection in ganglion cells. 
Virus also was subsequently found in a variety of cells in 
th e brain stem. These observations indicated that infection 
of the neural soma preceded Schwann or satellite cell infec-
tion. Baringer and Swoveland (1974) using electron microscopy 
also observed herpes simplex virus particles within the axon 
of trigeminal nerves of rabbits corneally inoculated with HSV. 
The axons were surrounded by mononuclear cell cytoplasm but 
not normal Schwa nn or satellite cells. The axons themse lv es 
were dis t incti ve ly abnormal, containin g a pro f usion of filaments 
and scattered vacuol es in which isolated herpes simplex v irus 
particles were ide n t i f ied. The herpes simplex virus par ti cles 
were identified. The herpes simplex virus particles 
within the axon were enveloped and in turn were contained 
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within membrane bound vesicles. Theses observations corresponded 
well with those made by Hill (1974) and Kristensson et al 
(1975). Because the intra-axonal particles have been f ound 
within similar vesicles or channels within the axon, it 
has been presumed by some that these are possibly profiles 
of the endoplasmic reticulum. The fact t hat the particles 
ha v e consistently been localized within such structure 
suggested that the travel of virus within the axon may require 
some special cellular transport mechanism such as t he 
endoplasmic reticulum (Baringer, 1975). 
In a series of careful experiments, Cook and Stevens 
(1973) found that spinal gangli a of mice were p ositive for 
herpes simplex virus within 20-24 hours aft er inoculation 
in the footpad. In the same studies, the time for one-step 
growth of virus in the mouse fibroblas t s was at least 4 hours, 
and it was considered likely that no more than six contiguous 
cells could be infected in the twenty four hours period. 
Thus, there was a gross discrepancy between the time that 
would be necessary for an ascending Schwann cell infection 
to arrive at the ganglia and the time at which virus could 
first be recovered from the ganglia. According to Stevens' 
observation (1975), the transport speed of the herpes simplex 
v irus within the axon was probably greater then 1.5 mm per 
hour. They also found that maximal titers of virus were 
consistently observed in the ganglia eralier than in the 
sciatic nerve. These r e sults were related to the relative 
permissiveness of the neurons compared to the supporting 
16 
cells. In addition, viruses could be found in axons, whereas 
infected satellite cells were only seen surrou n ding the infected 
neuron. 
Similar results also were found in Kristensson's study 
(1974). He found herpes simplex virus par t icles in the 
perikaryon of retinal ganglion cells and their axons under 
electron microscopy. He indicated that travel of the virus 
f rom the infection in the eye t o the lat e r a l geniculate body 
occurred wi t hin 72 hours, a period too short to be explained 
on the basis of c ~l l to cell transfer of infection. Thus, 
Kristensson suggested that an intra~axonal spread of the 
virus moving anterograde migh t occur. 
Opensha w et al (1978) demonstrated that the blockage 
--
of axoplasmic flow prior to inoculation prevents at least 
early ganglionic infection in the mouse. 
The phenomenon of retrograde intra-axonal transport 
was also examined by Kristensson et al (1978). They found 
--
that the neuron of trigeminal ganglia corresponded to those 
which had accumulated the . protein trace r, h orseradish 
peroxidase (HRP), after injecting the HRP into the point of 
viral inoculation on the cornea of the mouse. Such accumula-
t ion is probably the result of an uptake of the HRP in 
axonal endings at the site of injection followed by retrograde 
axonal transport to the nerve cells. 
c. Evidence for other pathway: 
A recent study by Lascano and Berria (1980) showed 
active multiplication of herpes simplex virus within the 
Schwann cells, but no intra-axonal particles were observed 
under t he electron-microscope. Some of v irions were found 
in the intercellular spaces. This su gg es te d another 
route for neural transport of herpes simplex v iru s, i.e. 
by a passive motion of the virions along the i nt ercellular 
spaces. 
Although the hypothesis of the cell-to-cell pathway 
in nervous tissue was not supported by some previous 
authors, it is not completely excluded at this time. 
Herpes simplex virus particles and he r p s simplex virus 
antige n were also found in Schwan n ce l ls, neurofibroblasts 
and satellite cells in some animal models. As Kristensson 
e t al (1974) said" the data presented in d icate that the 
long distance within the nerous system are spanned by 
means of the axonal transport mechanism, but, simultaneous 
cell- t o-cell infection also takes place, probably in 
the short distance viral spreading". 
Endoneural spreading has also been suggested. There 
are two obvious routes: the endoneural lymphatic channels 
and the blood stream. Cook and Stevens (1973) observed 
that the virus could reach the ganglia even though the 
mice were given antibodies and they suggested a route 
other than neural lymphatic channels and the blood stream 
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as the route of passage. However, viremia can be demonstrated 
in malnourished children with widespread infection, in 
certain immunosuppressed adults, and occasionally in . 
immunologically intact individuals (Becker et al, 1968; 
Naraqi et al, 1976; and Craig and Nahmias, 1973). 
3. Evidence for Latent Infection of Ganglia with HSV: 
The first demonstration of latent herpes simplex 
virus infection in spinal ganglia was acomplished by 
explanting ganglia from mice previously inoculated in the 
footpad (Stevens and Cook, 1971). The ganglia were 
maintained in vitro as organ cultures and the supernatant 
fluid from the ganglia was intermittently assayed for 
the presence of virus. After variable periods of in 
vitro culture, the herpes simplex virus was found in the 
supernatant fluid bathing the ganglia. In their experiments, 
examination of the ganglia in vitro by the fluorescent 
antibody technique and by electron microscopy failed to 
demonstrate either antigen or viral particles. 
In the same system (Stevens and Cook, 1973), infection 
of a rear footpad with herpes simplex virus-type 1 or 
herpes simplex virus-type 2 was followed by an acute 
infection bf the sciatic nerve, sacrosciatic spinal ganglia, 
dorsal roots, the spinal cord and the brain. During the 
acute phase, infectious viruses can be easily recovered 
from all these tissues. It is particularly important mo 
note that the infectious virus first appear in spinal 
ganglia by the second day, reach a peak by day 4, and 
disappeared by day 7. All surviving mice demonstrated a 
posterior paralysis, and latent virus could be demonstrated 
in sacrosciatic spinal ganglia, but not in nerve trunks. 
Stevens suggested that the latent viral infection probably 
persists for life in the mouse. 
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Stevens et al (1972) also demonstrated that herpes simplex 
virus could be recovered by explant cultures from the 
trigeminal ganglia of rabbits for up to six months after 
corneal inoculation. In an extension of these studies, 
Nesburn et al (1972) demonstrated in over 90% rabbit eyes 
recurrent ocular infection in daily conjunctiva swab culture 
after herpes simplex virus infection and over 70% of the 
trigeminal ganglia showed latent herpes simplex virus in 
organ cultures up to nine and a half months after corneal 
infection. At the same time, virus was consistently absent 
from similarly prepared cultures of nictitating membrane, 
conjunctiva, lacrimal giand, cornea, iris, fifth nerve, and 
brain. This study indicated that the likely site for latent 
virus was the trigeminal ganglia and no t o t her organs associated 
with the eye or the lacrimal apparatus in the rabbit modei. 
In 1973, Knotts et al further demonstrated that some 
proportion of herpes virus can be recovered from a presumably 
latent state within the central nervous system. They 
successfully detected herpes simplex virus in the spinal fluid 
of 4 of 53 mice inoculated in the footpad and from the brain 
stem of rabbits inoculated on the cornea. 
Cook et al (1974) demonstrated latency of herpes simplex 
virus within spinal ganglia by intraperitoneal transplantion 
of ganglia of mice previously inoculated in the footpad. 
Dur ing the same year, Walz, Price and Notkins (1974) had 
succeeded in establishing latent infections of local sensory 
ganglia in mice inoculated into the cornea, the lip, the 
footpad and the vagina. One year later, Hill et al (1975a) 
--
also induced a latent HSV infection in mice by ear inoculation. 
Price et al, {1975b) demonstrated latency of HSV 
within the autonomic ganglia (the superior cervical ganglia) 
after infection via the anterior chamber of the eye in mice. 
From all the above studies, latent infection of 
corresponding neural ganglion following primary site infection 
is well established. The trigeminal gnaglion is one of the 
most common sites of HSV latency. 
Other sites of latent herpes simplex virus infection 
however are not completely excluded. Scriba (1977) claimed 
that herpes simplex virus-2 could be recovered preferentially, 
and herpes simplex virus-1 exclusively, from the footpad (the 
site of primary inoculation) of latently infected guinea 
pigs. More recently, Hill, Harbor and Blyth (1980) similarly 
reported that they had recovered herpes simplex virus-1 from 
the skin of latently infected mice, although earlier attempts 
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by other investigators had been unsuccessful. HSV has 
also been recovered from adrenal medula (Cook and St evens, 
1976) and uterine tissue (Walz et al, 1977) of latently 
infected mice. 
4. Evidence that Neurons are the Cells Involved in HSV 
Ganglionic Infection: 
The concept tha t HSV remains latent in neurons has 
been drawn from several independent observations: 
a. Latent herpes virus can be recovered by organ cult ures 
from ganglia, but not from the adjacent nerve or nerve 
root, as mentioned above. Except for the neuron 
itself, both nerve and nerve root contain the same kinds 
of cells present in ganglia. This cer t a i n ly suggests 
that HSV might be latent in the neuro n , a cell which 
is unique to the ganglion. 
b. The morphology of HSV in neurons is different from its 
appearance in satellite cells or Schwann cells. 
Enveloped intracytoplasmic mature virus particles are 
found in neurons whereas only incomplete virus particles 
are found in Schwarm or satellite cells (Stevens and 
Cook, 1973). 
c. Cook, Bastone and Stevens (1974) looked at viral 
reactivation in latently infected mouse ganglia placed 
in Millipore chambers. These chambers were implanted 
in the peritoneal cavity of immune and non-immune mice. 
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Virus was detected initially only in neurons, indicating 
which cells of the ganglion harbored latent infection. 
In the same studies, radioactive markers during reactiva-
tion showed that DNA synthesis occurred first in neurons 
and subsequently in satellite cells. Highly specific 
DNA hybridization experiments confirmed that herpes virus 
DNA was being synthesized in these neurons. 
E. RECURRENT HSV INFECTIONS IN HUMANS AND ANIMALS 
Some of the stimuli which appear to cause a recurrence 
of herpes simplex virus infection in men and animals 
are: neurosurgery, trauma, fever, sunburn, UV-light and 
radiation, stress, epinephrine, bacterial infection, local 
arthus reaction, anaphylactic shock, prednisone (Underwood 
and Weed, 1974) and menstration (Segal , Katcher, Brightman 
and Miller, 1974). 
1, Stimuli for Precip it ation of Recurrent Herpes Viruses 
by Manipulatio n of the Nerve: 
. It has been reported that surgery · of the trigeminal 
n erve triggers herpes of the face in humans (Cushing, 
1904; Pazin e t al, 1978). 
Recently , Walz et al (1 974) sho wed that sciatic 
n e rve neurec t omy would reac tiv ate late nt HSV infection 
in dorsal root gan glia. I n their study, herpes simplex 
virus could be isolated from th e mouse ganglion as early 
as day 1 afte r n eurec to my . La t ent HSV infection of the 
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superior cervical autonomic ganglion was also reactivated in 
mice by post-ganglionic neurectomy (Price and Schmitz, 1978). 
Further, in rabbit which had recovered from herpetic 
ocular infection, the direct neurosurgical stimulation of 
the trigeminal ganglion, using a 0.75 x 5 mm tipped probe, 
proved to be strikingly effective in producing HSV positive 
cultures (83 %) in the eye within 48 hours of operation 
(Nesburn et al, 1976). In a series of experiments, they 
also stimulated the ganglion stereotaxically by low-voltage 
electric current through a 22-gauge electrode, by direct 
injection of 50 ng of epinephrine or by mechanical trauma 
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with a 14 gauge solid probe in chronically infected rabbits. 
They found that stereotaxic stimulation of the trigeminal 
ganglion produced a significant increase in positive cultures 
of the eye within 2 days. They also produced trigeminal 
dencrvation of the eye by retrobulbar electrocautery or using 
an insulated 22-gauge plantinum (with 10 % iridium) wire 
intracranially. They found that the temporary retrobulbar 
disruption of trigeminal nerve function in chronically infected 
ani mals caused a striking decr ea se in the number of positive 
herpes simplex virus cultures of the eye obtained during 
the 20 weeks immediately following surgery. The stereotaxic 
interruption of intracranial trigeminal nerve function prior 
to initial herpes s i mplex virus infection dramatically reduced 
the in c idence of peripheral recurrences of herpes simplex 
virus. 
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Green and his associates (1981) showed that physiological 
levels of current delivered via an electrode implanted 
ov er the trigeminal ganglion of latently infected rabbits 
induced reactivation and shedding of virus in the 
preocular tear film. 
2. Stimuli for Precipitation of Recurrent Herpes Viruses by 
Trauma: 
The role of trauma as a stimulus for inducing 
recurrent HSV infection has long been suspected and has 
recently been confirmed by Hill and his associated (1978). 
Mild t rauma induced in the mouse by stripping the originally 
infected skin with cellophane tape was shown to reactivate 
the HSV infection in the skin. Recurrent herpes simplex 
viruses developed at the site 2 to 5 days later. It was 
detected clinically by the development of erythema and 
vesicles and by the appearance of virus in the skin. On 
any one occasion about JO% of mice showed reactivated 
disease and increasing the severity of trauma did not 
increase this proportion. Blyth, Harbour and Hill (1980) 
treated latently infected mice with immunosuppressant 
dru gs (cyclophosphamide, prednisolone and azathiopr in e, 
antithymocyte serum, and silica) either alone or combined 
with trauma to the skin. Their results demonstrated that 
all these immunosuppressant drugs were much less effective 
t n an simple cutaneous manipulation (by cellophane taping 
six times) in inducing recurrent lesions. 
J. Stimuli for Precipitation of Recurrent Herpes Viruses by 
Fever: 
In keddie, Rees and Epstein's studies (1941), 70% 
of their artificial fever tr~ated pa t ients developed 
herpetic lesio n following treatment. In Warren's (1978) 
study, about 46% of the patient developed herpetic lesion 
after fever therapy. Recurrent intraoral herpetic 
infection was also observed in febrile illnesses by 
Greenberg et al (1969); and HSV was isolated three times 
as frequently from the febrile patie n t as from the non-
febrile control patients. 
In animal studies, Schmidt and Rasmussen (1960) were 
unable to reactivate HSV in the rabbit central nervous 
system by artificial fever. 
4. Stimuli for Precipitation of Recurrent Herpes Viruses by 
Sunburn, UV-light and X-ray Irradiation: 
It is common knowledge that sunburn precipitates 
herpes viruses. Despite the common occurrence of 
recurrent herpes lesions after sunburn, very little experi-
ment and data could be found on this subject for men and 
animals. 
Wheeler (1975) has done a pilot study on the effect 
of ultraviolet light on three patients. Two patients had 
recurrent herpes of the buttock and one on the thigh. All 
were treated with ultraviolet light from a clinical Hanovia 
hot quartz lamp during the quiescent, healed period of the 
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disease. Herpes was precipitated in the three patients 
in four of nine trials after giving 4.5 to 8 mi ni mal 
erythema doses of UV light. Itching or redness appeared 
in two to five days and vesicles appeared in three to 
five days. 
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Blyth et al (1976) induced clinical signs of reactivatio n 
by UV irradiation of the skin of previously infected 
mice ears. The doses used were just sufficent to cause 
erythema in most mice and the infectious virus appeared 
in the skin two to three days after this treatment. 
The effects of eye and head X-ray irradiation on rabb i ts 
who had recoverd from ocular infection with HSV was examined 
by Groer (1970). Head irradiation of 3,000 roentgens 
produced recurrence of the HSV virus (by daily cultures) 
in the eyes in a high (as high as 78 % in one experiment) 
percentage of the rabbits latently infected by corneal 
inoculation. On the other hand, eye irradiation produced 
no significant reacti v ation of the virus in the irradiated eye. 
Recently, Openshaw et al (1979a) showed in vivo 
reacti v ation of latent herpes simplex virus in trigeminal 
ganglia by using 550 rads of body X-ray irradiation in 
mice. The incidence of reactivation in trigeminal ganglia 
in their studies was 20 to 40 %. 
5. Stimuli for Precipitation of Recurrent Herpes Viruses by 
I' 
Emotional Stress: 
Based on clinical observations, herpes labialis and 
facialis have long been associated with situations of 
emotional trauma and stress. Blank and Brody (1950) 
have reported on the characteristic traits of individuals 
affected with frequent reactivation of herpetic lesions. 
They studied six male and four female patients who were 
placed under psychiatric care for treatment of their 
herpes. There was a temporal relationship between the 
beginning of the therapy and relief from their recurrent 
disease. 
6. Stimuli for Precipitation of Recurrent Herpes Viruses by 
Epinephrine: 
Schmidt and Rasmussen (1960) tested a variety of 
suspected chemical compounds in rabbits which had previously 
been inoculated intracerebrally with herpes simplex virus 
after partial immunization. The precipitation of herpetic 
encephalitis was noted when the animals were challenged 
with adrenaline (2 mg parenterally). Within three to 
eight days, the rabbits became encephalitic and subsequenely 
died, 
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Kibrick and Laibson (1971) attempted to induce reactiva-
tion of herpetic keratitis in rabbit with either parenteral 
epinephrine or topical epinephrine ointment. Topical 
epin€8)hrine ointment was associated with an increase in 
recurrences of virus as comapred with recurrences during 
preceding, concomitant and following control periods in 
the same and other rabbits. The incidence of these 
recurrences has ranged from 25 to 70 percent in the experi-
ments. Kibrick (1969) also described the intermittent 
recovery of herpes simplex virus from rabbit eyes for 
periods up to three years after initial infections. This 
indicates that once this virus has been introduced into 
the rabbit cornea, a long-term, latent infection is produced 
which persists for the life of animal. 
Recently, epinephrine iontophoresis into rabbit eyes 
was also used as a method for inducing ocular HSV-1 shedding 
during the latent phase of ocular HSV-1 infected rabbits 
(Kwon et al, 1981). Epinephrine iontophoresis resulted 
in ocular HSV-1 shedding in 75% of eyes, as compared with 
saline iontophoresis in 12% and untreated in 12% of eyes. 
7. Stimuli for Precipitation of Recurrent Herpes Viruses by 
Bacterial Infection: 
Numerous clinical observations have confirmed that 
pneumococcal pneumonia and meningococcal meningitis are · 
frequently associated with episodes of recurrent labial 
herpes o Recent laboratory experiments with D. Pneumonia 
have further confirmed such a relationship. Stevens and 
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Cook ( 1975) instilled Diplococcus pneumoniae ! intratracheally 
into mice harboring latent infection in sacrosciatic 
spinal ganglion. The ganglia were removed from the mice 
that <6urvived the pneumonia. Herpes simplex virus reactiva-
tion was demonstrated by the viral DNA hybridization 
technique after one day of pneumococcus infection. The 
viral directive assay on such ganglia confirmed 
reactivation of herpes simplex virus infection 1,2, 
and 3 days after the pneumococcus infection. The viron 
was also noted to be traveling both proximally, and 
distally in the nerve trunk by in vitro cultivation. 
The fever produced by pneumococcus infection in this 
study could be a stimulus for the reactivation. 
8. Stimuli for Precipitation of Recurrent Herpes Viruses 
by Local Arthus Reaction (Anderson and colleagues, 1961), 
and by Anaphylactic Shock (Good and Campbell, 19~5 and 
1948) I 
9, Stimuli for Precipitation of Recurrent Herpes Viruses 
by Immunosuppression (Tobe discussed in the next 
section). 
F. CELLULAR MECHANISMS OF LATENT AND RECURRENT HSV; HYPOTHESES: 
1, Characteristics of Cells Harboring Latent Infection: 
In general, when herpesvirus infects a cell, the 
cell's biosynthetic mechanism is directed to make new 
virus particles. So completely is the infected cell 
dedicated to the production of viral components that 
it is unable to maintain its own biochemical equilibrium. 
The cell dies, releasing myriad virus particles to 
\ 
spread and infect surrounding normal cells and repeat 
the process. 
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Clearly this lethal pattern of infection cannot occur 
in cells that harbor latent virus. Latently infected cells 
must restrict HSV replication, or the cells would die during 
primary infection or recurrence, making further recurrence 
impossible. This restricted nonlethal replication of HSV 
certainly must be true of mammalian neurons, wh ich do not 
regenerate. 
There is at least one experimental precedent for herpes 
pr oducing this kind of restrictive infection. As Stevens and 
Cook (1971b) showed, mouse peritoneal macrophages produce 
HSV proteins and DNA, synthesizing nonenveloped and pro bably 
noninfectious virus. These special cells do not die in the 
proc e ss, as do other cells. Neurons harboring latent infec-
tion may act in a similar fashion. For example, skin HSV 
repeatedly affects the same small areas, indicating that the 
same neurons are involved in each recurrence, and apparently 
do not die. 
In addition to neuronal infection being nonlethal most 
of the time, there must exist a means to limit cell-to-cell 
spread in the nervous system. This inference stems from the 
great prevalence of localized recurrent skin, oral, genital, 
and ocular herpes and the rarity of herpetic encephalitis. 
In the last, catastrophic condition, HSV spreads within the 
CNS and causes cell death. The spread of HSV within the 
' nervous system may be restricted by the Schwann and satellite 
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cells that completely surround the neurons. The restric-
tion may be enhanced by the macrophages surrounding the 
neurons with active HSV replication, as demonstrated by 
Baringer and Swoveland (1974a). Thus macrophages and 
satellite cells may act as insulators, preventing cell-to-
cell spread of virus. This is consistent with the evidence 
that these cells do not normally support lethal host cell 
HSV infection (Nesburn, 1979). The restriction of the 
spread of HSV within the neural axon by the myelin sheath 
was also suggested (Dillard et al, 1972; Cook and Stevens, 
197 3) • 
2. Role of the Immun e System in HSV Infection: 
The immune system plays an important role in HSV infec-
tion, but the actual nature of this control is unknown. 
The complicated roles of humoral and cell-mediated 
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immunity in HSV infection are being intensively investigated. 
Prior immunization can prevent acute an d latent 
phases of herpes simplex virus infection. For example, 
Price and co-workers (1975a) showed that immunization with 
HSV-1 could prevent ganglionic infection but the degree 
of protection varied according to the site of challenge. 
Latent ganglionic infection can develop in immunized animal 
despite the presence of high titers of neutralizing 
antibody. c Even if immunization does not prevent latent 
gangl .ionic : infection, ,experiments :.to ·date ;.sugges .t tha"t . -- ~ ·· 
immunization may benefit the host both in the acute and 
latent phases of herpetic viral infection. For example, 
Walz and co-workers (1976) showed that fewer cells in ganglia 
were infected at the productive stage (acute phase) of HSV-1 
infection in immunized as compared with unimmunized mice. 
Passive administration of immune serum tb herpes infected 
animals has also been studied. Administration of anti-herpes 
serum to mice infected with this agent was able to prevent 
acute infection in trigeminal ganglia and the eventual 
establishment of latency (Klein, 1980). In the same studies, 
immune serum reduced the . amount of free virus in the ganglion 
during both acute and latent phases. In addition, passive 
administration of immune serum to herpes simplex virus infected 
mice has been shown to decrease the incidence of both the 
mortality and the neurological disease (McKendall et al, 1979). 
--
In vitro studies on the effect of anti-herpes simplex 
virus antibody on acute . and latent phases of the viral infec-
tion were investigated by Openshaw et al (1979). They showed 
that the titer of virus was markedly reduced, but the infec-
tion was not eliminated in the presence of antiviral antibody 
in obht acute and latent phase infection. In addition, they 
slb.udied the immune control of this acute ganglionic infec-
tion in immunocompetent and T-cell deficient (nude)mice after 
herpes simplex virus inoculation by the corneal route. In 
immunocompetent mice the virus titer in ganglia decreased 
from four days after inoculation to undetectable levels twelve 
days after inoculation. Besides defective cell-mediated 
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immunity, the nude mice did not form a neutralizing antibody 
respons .e to herpes simplex virus. These results indicated 
that a developed immune r.esp_ons-e is needed to eliminate the 
acute stage of the ganglion infection. To study further the 
role of antibody, immunocompetent and nude mice in the same 
experiment were given anti-HSV antibody after inoculation 
and on alternate days for eight days. This treatment in 
effect bypasses the acute infection in immunocompetent mice 
(negative homogenated, positive ganglionic explant cultures). 
However, despite identical median antibody titers up to 
eight days after inoculation, the acute infection was not 
eliminated in the nude mice. By showing that antibody alone 
cannot eliminate the acute infection, these results support 
the argument that cell-mediated immunity is a necessary 
component of the host's defense against herpes simplex virus 
ganglionic infection. 
Immunologically normal people have recurrent herpetic 
disease, although immune-deficient individuals have more 
severe episodes (Montgomerie et al, 1969; Muller et al, 1972). 
-- -
Clinically, reactivation of herpes simplex virus occurs 
commonly after organ transplantation (Montgomerie et al, 1969; 
Rand et al, 1977; Naraqi et al, 1976; Pass et al, 1979; and 
Meyers et al, 1980). Thus, the immunologic response could 
play a role in the precipitation and healing of the lesions 
of recurrent herpes disease. 
It is well known that the patient with high titers of 
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serum antibodies may still develop recurrent herpes disease. 
It has been suggested, however, that there may be differences 
in a patient's antibody activity between the recurrent and 
latent phases of herpetic infection. Ratner and Smith (1980) 
found that subjects with oral herpes lesions at the time of 
serum sampling had higher proportions of neutralizing antibody 
(determined by plaque reduction) as compared with total 
antibody (detected by radioimmuno assay). They questioned 
whether this difference in humoral neutralizing ab i lity 
might be related to the recurrence of oral herpes lesions. 
Lopez and O'reilly (1977) reported that the individuals with 
recurrent disease have higher neutralising antibody t iters 
than the individuals with antibody titers but no history of 
herpetic infection. 
The role of cellular immunity in recurrent herpe s simplex 
has recently also been investigated. When recurren t HSV 
34 
lesions were present, patient with recurrences had signi f ica nt ly 
higher level s of cell-mediated cytotoxicity in circulating 
mononuclear cell than when such lesion were absent (Reichman 
et al, 1977). When lesions were absent, the cytotoxicity in 
patient with recurrences was not sigificantly different from 
levels in s ero-positive individuals without recurrence. These 
results indicated that patients with recurrent herpes simplex 
virus infections have an intact cell mediated cytotoxic 
activity response. 
On the other hand, a marked but transient decline in the 
production of lymphocyte-derived chemotactic factor was 
observed in genital herpetic infective patients at the time 
of clinical recurrence (Rattary et al, 1980). 
Donnerberg et al (1980) showed a significent impairment 
of leukcyte migration inhibition factor (L I F) in both 
peripheral blood lymphocytes and spleen cells from guinea pigs 
with latent HSV infection and histories of recurrent disease 
during asymptomatic period (quiescent) as compared with the 
f unction of LI F o f t he same cells from guinea pigs without 
clinical recur ren t disease (seropositive controls). Decreased 
interferon production has also been correlated with an 
increased frequency of recurrent herpes simplex virus infec-
tion (Rasmussen et al, 1974). 
Recently, cyclophosphamide,an immunsuppresant agent, was 
demonstrated to be capable of producing herpes simplex virus 
recurrent disease in mice (Openshaw et al,1979; Kurata et al, 
1978; Hough and Robinson, 1975). Cyclophosphamide has been 
shown to have a differential effect on lymphoid tissue, its 
action against B-lymphocytes being far more severe a nd long 
lasting than against T-lymphocytes. But the precise mechanism 
involved with reactivation of herpes simplex virus by 
cyclophosphamide is still not clear. 
The hypothesis that latent and recurrent HSV are 
under immunological regulation was recen t ly proposed; 
this will be discussed later. 
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J. Neuronal Hypothesis of HSV Recurrence: 
Fifty years ago Goodpasure (1925) discovered the 
avid neurotropism of HSV virus and proposed that the central 
nervous system was the reservoir of HSV between attacks. 
In an extensive review of HSV recurrence literature, 
Paine (1964) proposed what Nesburn et al (1976) later called 
the "neuronal hypothesis"- suggesting that latency, 
whatever its form, occurs in neurons and that HSV is 
transported to the periphery, where the lesions appear 
via the axons. The evidence outlined here and elsewhere 
(Baringer, 1975; Stevens, 1975) lends support to this 
hypothesis of the underlying mechanism in HSV's pathobiology. 
Nesburn and Green (1977) suggested a scheme to 
explain HSV recurrences based on the neuronal hypothesis. 
According to their proposal the major component of HSV 
recurrence involves reactivation of latent infection in 
neurons with centrifugal axoplasmic transport of virus or 
viral components to the periphery. The virus replicates 
in the skin, mucosa, or other tissues and is released in 
the tear, saliva with or without production of local 
ocular infection or lesions. 
This is the sequence of their schemes: 
' 
a. (Primary and Sensory) clinical or subclinical infection. 
b. Latent infection of neurons: 
The virus passes via nerve endings to the axons of 
the nerve. It establishes a latent infection in the 
J6 
neurons of the ganglion and nucl e us. The virus disappears 
from the peripheral tissues. 
c. Viral reactivation in neurons: 
A spontaneous or triggered reactivation of viral 
synthesis occurs in the neurons. The virus passes via 
the axons to the peripheral tissues. 
d. Peripheral viral synthesis and shedding: 
HSV replicates in the peripheral tissues and is 
shed into the tear, or saliva. 
e. Possible recurrent clinical disease: 
Clinical disease becomes manifest if the vi rus is 
present in high titer or if host defenses are compromised. 
f. Re-establishment of latent infection of neurons: 
Whether or not clinical infection occurs, the HSV 
replicating in the tissues passes again via the nerve 
supply to the neurons perhaps reestablishing latent 
infection. The cycle is thus completed. 
4. Ganglionic Trigger vs Skin Trigger Hypothesis: 
a. Ganglionic trigger theory: 
The common interpretation of the neuronal hypothesis 
could be called the ganglionic trigger theory. A 
stimulus causes a latently infected neuron to switch 
) 
on its herpes bio~ynthetic pathway. Th e neuron produces 
virus, which travels down the axon to the peripheral 
tissues. If the conditions are proper at the periphery, 
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lesions may become manifest. In the ganglionic trigger 
theory it is assumed that HSV replication is triggered 
in the ganglion on a relatively infrequent and irre gular 
basis(Hill and Blyth e , 1976). 
b. Skin trigger theory: 
To reconcile the inconsistencies previously mentioned, 
Hill and Blythe (1976) offered another interpretation of 
the neuronal hypothesis, called the skin trigger t heory. 
Th ey hypothesized that (1) HSV is produced on a re gula r 
basis in ganglion cells and (2) the virus co n sist en t ly 
reaches the skin. They further postulated that microfoci 
of infection develop repeatedly but are eliminated by 
local host defenses. In rare instances changes occurring 
in the skin allow lesions to form. These changes (e.g. 
trauma, UV radiation, fever, stress) may stimulate loc.al 
virus production and/ or temporarily suppress local skin 
defenses. 
The skin trigger theory would explain how virus 
could be latent in the central nervous system and produce 
lesions so quickly in the periph er y. It really relies on 
the neuronal hypothesis, but it emphasized that peripheral 
stimuli more commonly trigger peripheral virus release 
~ 
and lesion formation. Peripheral lesion formation may 
be controlled primarily by cell-mediat ed immunity and 
interferon whereas reactivation of virus in the neuron 
may be controlled by humoral immunity (Stevens, 1975). 
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The ganglionic trigger and skin trigger theories 
are mutually compatible. Most likely, both mechanisms 
are at work (Nesburn, 1979). 
5. Dynamic vs Static State Hypothesis: 
Recurrent herpes at the animal and tissue level has 
been discussed. The focus will now turn to the cellular 
and subcellular mechanisms of herpesvirus proposed to 
explain its latency and recurrence. Roizman (1974) theorized 
that recurrent herpes infection could be the r e sult of 
latent virus in either a dynamic or a static state. 
a. Dynamic state hypothesis: 
Roizman (1974) proposed that whole virus or 
subviral components might be produced continuously by 
latently infected cells. The most sophisticated form 
of latency would involve the acutual incorporation of 
herpesvirus DNA into the host cell's own DNA structure. 
The proper provocation would stimulate or derepress 
the HSV genetic material and cause increased synthetic 
activity, which would produce whole virus particles. 
b~ .Static state hypothesis: 
Roizman's static state hypothesis assumed that 
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latent viral genetic material or virus exists intracellular-
~ 
ly in a nonreplicating form. Only when stimulated or 
derepressed does viral synthesis take place, with the 
consequent recurrence of infection. 
6. One-way vs Round-trip Hypothesis: 
This leads us to consider an ~ther, as yet unan swered, 
pa r t of the herpes recurrence problem: the role of peripheral 
virus production in the maintenance of la ten cy. Specifically, 
is there a latency-reactivation cycle? 
a. One-way hypothesis: 
The one-way hypothesis proposes that the informa-
tion for repeated recurrences is never lost from the 
latently infected cell (Klein, 1976); each episode is 
thought of as a one-way transmission of the virus from 
the neuron to the peripheral target organ. Local de f ense 
mechanisms would eliminate locally produced virus but 
would have no effect on the permanently situated vi r us 
genetic material incorporated into the neuron nucleus. 
b. Round-trip hypothesis: 
The round-trip hypothesis supposes that maintenance 
of latent infection requires peripheral replication of 
virus to reestablish latent neuronal infection (Klein, 1976); 
whether viral genetic material is in a dynamic or a 
static state, ther is at least a chance to rid the 
organism of latent infection. Suppression of peripheral 
virus synthesis on a long-term basis might work. For 
instance, topical interferon a pplied to the eye prevents 
recurrences of herpetic keratitis in animals and in man 
(Kaufman et _ al, 1976; Nesburn et al, 1971; Sugar et al, 
1973). Decreasing the frequency and severity of per ip h eral 
recurrences might eventually decrease the neurons 
harboring latent infection. 
40 
7, Immune Modulation vs Immune Elimination Hypothes i s: 
For the role of i mmune system in establishing HSV 
latency, two alternative hypothesis have been proposed 
(Openshaw et al, 1979). 
a. Immune modulation hypothesis: 
It is proposed that an acute herpes simplex virus 
infection in ganglion cells is modulated by immunity 
in such a way that the infection is converted to a 
nonproductive or latent stage. 
b. Immune elimination hypothesis: 
The second hypothesis, immune eliminatio n, postulates 
two populations of susceptible cells in ga n g li a. An 
acute infection is set up in one cell po p u l ation, while 
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a nonproductive (latent) infection occurs in the secondary 
type. Immunity may act to recognize and eliminate 
the productively infected cells, thereby allowing the 
detection of the underlying latent infection by 
explant a t i on of ganglia. 
8. Other Postulated Mechanisms: 
a. Roizman (1974) proposes a biochemical explanation 
for the maintenance of the latent infection in n eur ons. 
In situ, these cells la ck the specific transcr i p t ase 
necessary for herpes simplex virus multiplication. 
Since the viron does not contain a transcriptase the 
genome remains arrested in the cell. The enzyme would 
become available in the neuron only after stimulation by 
factors disrupting the physiological eQuibibrium of the 
organ. This would lead to the recurrent herpetic eruption. 
b. A immunologic hypothesis for latency and recurrent herpes 
was advanced by Lehner et al (1975). The Fab site of 
the anti-HSV antibody molecule would bind to a surface 
antigen induced by virus in the latently infected cells, 
whereas the Fe site of the IgG molecule would bind to the 
Fe receptor of the cells. This double binding of the 
antibody to the cell may suppress viral activity and 
protect the cell from lysis by complements, kill i n g c ells, 
macrophages and T lymphocytes. Recurrence-inducing 
factors might weaken the Ig G bond to Fab and Fe receptors 
on the cell, thus depressing the expresion of viral 
genome, permitting viral multiplication, axonal migration 
and virus shedding from nerve endings near the epithelium. 
Local modification in cell mediated immunity would then 
enable local virus proliferation and the formation of the 
recurrent lesion. This hypothesis takes into account 
the persistence of antibody in patients with recurrent 
herpes, postulates 1 only local modifi ca tions in cell 
mediated immunity, and permits the experimental verifica-
tion of some of its aspects. 
c. HSV-antiserum (IgG) had been suggested as an important 
factor in maintaining herpes simplex virus latency (Stevens 
and Cook, 1974). However, some experiments described by 
Sekiza wa et al (1980) using a mouse model throw considerable 
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doubt on this idea. Latent infection was established in 
mice which were protected during the primary infection by 
the administration of immune antibody so that their own 
immune systems were not primed. It was shown in the majority 
of animals that as the passive antibodies faded that latent 
infection was maintained. These experiments could exclude 
the important role of antibody in the maintenance of latency, 
but could not exclude the p ossible ro-1.e of antibody in the 
establishment of latency. 
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MATERIALS AND METHODS 
A. CELL CULTURE 
Green mondey kidney (CV-1) cells were prov id ed by 
Dr. Bernard Fi e lds, Depar tment of Microbiology, Harva r d 
Medical School . Th e c ells were grown at 376c with Ea gle's 
Minimal Essential Media x4 (MEMx4) with Earle's s alt s.* 
The media was supplemented with 10% fetal calf se r um (FCS) 
which was heat inactivated at 56°c for half hour bef or e 
use. All cultures contained 50 units/ml of penicillin and 
50 ug/ml (50 units) of streptomycin. Amphotericin was 
n ot used. 
B. STORAGE OF CELLS 
Flasks containing CV-1 cells grown for 2-3 days were 
t reat ed with 0.25 % typsin in Hanks balanced salt solution 
t o loosen the cells. Trypsin action wa th en neutralized 
by add it i on of media containing 10% FCS. The cells to be 
f rozen were centrifuged gently (800-1,000 rpm for 10-20 min.). 
* MEMx4: MEM (Eagle) Medium f or mula #78-5230. (W/Earle's 
Salts, 1 x L- Glutamine, 4 x Amino Acid, 4 x Vitamins), 
GIBCO, Grand Islands, N. Y. 
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After the removal of the supernatant, the pellet was resuspended 
in a storage medium containing 10 % DMSO (Dimethylsufoxide) 
and 90 % fetal calf serum to yield a final c ell concentra-
tion of 1 x 10 6 c e lls/ml. The cell suspension was then 
dispensed in 1 ml aliquots into storage vials.* The vials 
were then placed in a o0 c freezer for one to two hours, 
subsequently placed in REVCO** freezer (approximate -5 0° C) 
for 24 to 72 hours and finally stored in a liquid n itro gen 
freezer until required. 
C. PREPARATION OF VI RAL POOLS 
The Rodanus strain of herpes simplex virus type 1 (HSV-1) 
provided by Dr. S. Kibrick (P. Laibson and S. Kibrick, 1969) 
was utilized for these studies. This virus, recovered from 
the lung of an eight months old infant with eczema h er peticum, 
was isolated on the chorioallantoic membrane of a fertile 
hen's egg. Viral pools were prepared by infecting confluent 
cultures of CV-1 cells grown in T-75 flasks. Thirty six to 
forty eig ht hours after inoculation, 90 % of CV-1 cells 
displayed cytopathic effect. The media, which contained the 
virus, were poured off and saved. Five ml of the media were 
* NUNC, Denmark. 
** REVCO freezer, REVCO Sub Zero Equipment, REVCO INC., 
Deerfiel p , MICH. 
added to the cell flask and the cells were scraped off 
with a rubber policeman. The cell suspension was collected 
and the cells were lysed by altern at ely freezing and thawing 
three times, using a dry ice-ethanol solution. The cell 
debris and virus mixtures were centrifuged at 1,500 rpm 
for ten minuts. The supernatant containing the virus was 
divided into 10 ml fractions and frozen at -6o 0 c in a REVCO 
freezer. All manipulations were done under sterile condition. 
D. CYTOPATHIC EFFECT· ( CPE) OF HSV IN CV =--1 ···CELL CT.'.TT..iTURES 
Herpes simplex virus (HSV) produces characteristic and 
easily recognizable changes in cultures of CV-1 cells. 
These cells were used almost exclusively in these studies, 
although initially rabbit kidney cells and IMR-90 (human 
lung fibroblast) were also tested, The cytopathic effect of 
HSV on infected CV-1 cells results in degeneration and 
death. At first, mitosis is inhibited and intranuclear 
inclusion bodies are formed; these are very characteristic 
for HSV infection (Staab et al, 1965). In our studies, two 
types o:f CPE were apparent in HSV infected CV-1 cell cultures: 
a. both small and large refractile round cells and 
b. polykaryocytic syncytial cells. 
In preliminary studies, the time course of HSV infec-
tion on CV-1 cells was observed. Confluent CV-1 cell cultures 
were inoculated with 1 PFU HSV per 2,000 cells. HSV was 
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.obtained only from intracellular homogenates 20 hours after 
the inoculation. The culture medium did not show the presence 
of the virus until 36 hours after the inoculation. Fifty 
two hours after the inoculation, a few CPE foci surrounded 
by apparently healthy cells were observed; however, the 
entire cell sheet was not completely transformed until tw o 
to five days later. 
E. QUANTITATION OF HSV 
Quantitation of HSV was made either by plaque assay or 
tissue culture infective dose (TCID 50 ) method. The plaque 
assay for herpes simplex virus was adopted from Garabedian 
and Scott (1976). Serial ten-fold dilutions of virus were 
made in 2 ml MEMx4 with 10 % inactivated fetal calf serum; 
0.5 ml of each dilution was then added to each of three 60 
mm tissue culture dish containing confluent CV-1 cells. 
After JO minutes in 5% CO2 in a 37°c incubator, the _ super-
natant was remove d f rom t he cell sheet, and 4 to~ ml of cold 
methyl cellulose-growth media (MC, methocel MC, Dow Chemical 
Company, 7.5 gms MC in 250 ml distilled water, autoclaved 
and added to 2 x MEMx4, 0.5 % FCS and 50 units penicillin and 
Streptomycin) was overlayed onto the mon o layer. Subsequently, 
the cells were incubated for approximately 72 hours at 37°c 
in a CO2 incubator. The plates were then placed in the 
cold room (4Pc) for JO minu t s and afterwards the overlay was 
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removed. The cells were washed with 0.85 % NaCl, and fixed 
in 97 % methanol. The plaques were counted with the aid of 
an ACCU-LITE.* 
The tissue culture infective dose 50 (TCID 50 ) method 
was also occasionally used. A se r ial ten-fold dilution of 
the virus was made as previously described. 0.1 ml of each 
dilution was added to each of two culture tubes of c onf luent 
CV-1 cells. The cultures were maintained in 10 % FCS in 
MEMx4 and examined each day for seven consecutive days for 
any evidence of CPE. Those cultures which recei v ed concentrated 
virus developed CPE within 24 hours whereas those cultures 
which received diluted virus developed CPE at a later tim e . 
The end point was established when no new occurrence of CPE 
was seen. When only one of a duplicated pair of tubes 
developed CPE, the titer was expressed as the log of the 
reciprocal of the original viral dilution which had been added 
to the cultures. 
F. ANIMALS 
Four weeks old, white, male Swiss CD-1 strain** mice 
were kept at 15-20 animals per cage and were cared for by 
the animal care personnel of Boston University Medical Center. 
* ACCU-LI TE: ACCU TECH Corp., N.Y., N.Y. 
* Charles River Laboratory, Cambridge, MA. 
They were all placed on the same diet of mice chow. The mice 
were anesthetized as required by Chlorohydra t e* (0.1 ml/gm 
body weight). Both left and r ight corneas were scratched 
five times with a · 30 gauge disposable needle and one drop 
of HSV containing 2 x 10 6 PFU/0.5 ml Rodanus strain of virus 
was inoculated. The infected mice were put back in th e 
cage and cared for as described above. 
G. ISOLATION OF HSV FROM THE MOUSE GANGLION 
The ganglionic tissue were removed under a dissecting 
microscope using sterile technique. After disinfecting the 
neck skin of the mo~se with an alcohol sponge, the c ervical 
skin and muscles were cut open. The superi a l cervical 
gangl i a are located on the internodors .al side of the common 
carotid artery and they wer e carefully removed by f or ceps. 
The trigeminal ganglion is located on the base of the brain, 
therefore the brain was removed surgically first and then 
the ganglia were removed with a dental Gracey# 1J & 14 
curete**· Subsequently, the ganglia were studied either by 
the explantation method or by the homogenization method. 
For the former, the whole ganglion was washed with PBS and 
* Chlorohy drate: Fisher Scientific Company, Pittsburgh, PA. 
* Gracey #1J & 14: Hu-Friedy, J118-J6N. Rcokwell St. 
Chicago, ILL. 
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then placed in a 6 11 c ulture tube containin g confluent CV-1 
cells maintained in MEMx4 media containing 10 % FCS. The 
medium was changed every 10 to 15 days. The cultures were 
examined for 30 consecutive days for CPE characteristic of 
HSV. For the homogenization method, the ganglia were 
homogenized by either a Potter Elvehjem Tissue Grinder* or 
a motorized tissue grinder. The homoginates were diluted 
to 1 ml with MEMx4 growth media and stqred in a REVCO 
freezer. After freezing and thawing t _ e homogenate three 
times by dry ice-acetone, half of e a ch ganglian homogenate 
was put in a culture tube containing a confluen t sheet of 
CV-1 cells, and incubated in a 37°c inc ub ator for 30 minutes. 
Afterwards, each homogenate in the tube was discar d ed; 
each tube was incubated again after 1.5 ml new media was 
added. The CV-1 cell cultures were then examined for HSV 
CPE for 15 days. 
H. ANTIBODY ASSAY 
The microneutralization test for HSV antibody was 
adopted from Pauls et al (1967), Rawls et al (1970), and 
Stalder et al (1975). The serum was collected by cardi ac 
p uncture from the mouse and serial two fold dilutions were 
* Potter Elvehjem Grinder: Fisher Scientific Company, 
Pittsburg, PA. 
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prepared using g wt h media, beginning with a 1:10 dilution 
of the serum. To each set of serum dilutions, 0.05 ml of 
5 x 104 PFU/ml HSV dilution was added, the mixtures were 
then incubated at 4°c for an hour. Five hundredths ml of 
the 3 x 105 /ml cell suspension was mixed with the same 
amount of preincubated sera-virus mixture in each well of 
a 96-well tissue culture plate. After five days of inc uba -
tion in a 37°c CO2 incubator, the cells were fixed wit h 
95% methyl alcohol, stained with 1% crystal violet, and then 
examined for CPE. 
I. VARIOUS METHODS _WHICH WEF~E ATTE~PTED '.1'.0 
REACTIVATE LATENT HSV INFECTION: 
All t he mice used in the following reactivation studied 
received corneal inoculations with HSV at least 4 weeks 
prior to these experiments. They were anesthetized with 
chlorohydrate (IP) when the different methods of reactivation 
were tested. 
1. Trauma: 
Both thermal and mechanical trauma were applied to the 
cornea of the HSV latently infected mice. For thermal 
trauma, a soldering gun, which was heated to around 700°F, 
was used. In earlier experiments, both eyes were gently 
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burned with the soldering gun for app r oximately 1 second. 
A white cloudy lesion on th e cornea \ a s observed after 
burning. In later experiments, only one eye from each animal 
was purned for 10 seconds; the contralateral eye served as 
contral. These animals were sacrificed on different days 
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after burning and the ganglia were examined for viral reactiva-
tion by both homogenization and explantation methods. 
For mechanical trauma, a soft tooth brush (Colgate) 
was used to brush the cornea fr om f our different directions. 
Epithelial damages were observed under a slitlamp with and 
without fluorescent stain in all the corneas mechanically 
injured by the brush. In the first group, corneas were 
brushed twice with a 12 hr interval; while in the second 
group, the corneas were brushed eight times with a 1.5 hr 
interval. Eye swabs were taken from both groups of mice 
after chlorohydrate anesthesia. The cotton swab was rotated 
in the lower · cul-de-sac, th n swept across the corea into 
the upper cul-de-sac and removed. Cultures of the eye swabs 
were maintained in 6 11 tubes containing CV-1 cells for 7 days. 
The cells were examined daily for characteristic CPE. 
2. Fever: 
The latently infected mice were placed in a 37°c incubator 
with normal food and water supply for 20 hours. Eye swabs 
were taken daily as described abo v e both before and after 
the fever stimulation for one week. HSV assay on the ganglia 
by both explantation and homegenization met h ods were done 
on different days follo wing t he fever stim ul a t ion. 
3, Cyclophosphamide (CPA): 
Cyclophosphamide* was provided as a dry powder and 
stored at room temperature. CPA solu t ions were prepared 
in sterile distilled water immediately before use. 
To determine its toxicity, different doses of CPA were 
injected into mice intra-peritoneally and the mortality rate 
was determined over 17 consecutive days. For the re acti v a -
tion studies, 300mg/kg of CPA was used. Daily e y e swabs were 
taken for two weeks after CPA t reatment. In addition mi ce 
were sacrificed and t he gangl i a were examined with the 
homogenization method on different days following the 
treatment. 
4. Ultraviolet light: 
Anesthetized mice were placed in a cage lined with te n 
f oil and they were radiated by short-wave-length UV light** 
placed at the top of the cage (about 30 cm above the mice). 
The mice were exposed to UV radiation for 24 hours on day 0 
~~ CPA: S I GMA Chemical Company, St. Louis, MO. 
** UV· Lamp: General Electric, F15T8-BLB, 15 watt., Blackligh t . 
53 
and for 2 hours daily thereafter for 2 weeks. Daily eye 
swabs were obtained during the 2 weeks period of radiation 
treatment. Each swab was inoculated into a tube containing 
a monolayer of CV-1 cells. The tubes were incubated at 37°c 
and examined daily for CPE. 
5 . Stress: 
To produce stress, latently infected mice were 
suspended from their front feet while the rear feet were 
touching the surface of a bowl of water for 24 hours. Daily 
eye s wabs were taken for two weeks after the physical stress. 
These swabs were examined as above in cultures of CV-1 
cells for HSV CPE. 
J. EXPERIMENTAL DESI GNS 
The experimental designs for our studies are summerized 
in the table below. 
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Experimental Designs: 
Part 1: 
* * * * * * * * * * * * * * I I I I I I I I , I I I 
I 2 4 6 8 10 12 14 
Part 2: 
a. * * * * 
I at least s 2 4 6 8 
4 weeks 
b, lj_ ti. ti. #, #. Ii. ti. #. It Iii 
I at least -7 -6 -4 -2 s 2 
4 weeks 
or 
#. #. #. #. #. #. #. #. #. 
I at least s 2 4 6 8 
4 weeks 
Time (days) 
I: Corneal inoculation with HSV. 
*: Assay of mouse ganglia for virus. 
#; Eye swabes obtained. 
S: Stimuli used to induce recurrent infection. 
I * .a JO 
#. Iii .# 
4 
ti. t i 
10 12 
ti. It. 
6 7 
i #. 
14 
8 
* .. 
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RESULTS 
A. THE MOUSE MODEL OF HSV CORNEA INFECTION 
The initial studies were carried out to define the 
characteristics of trigeminal and superior cervical gan gli on 
infection caus ed by corneal inoculat i on wit h the Rodanus 
s train of HSV-1. The virus was demonstratable by eye-swa b 
cultures for several consecutive days after inoculation, 
although clinical signs of herpes simplex were absent a t 
this early stage. Skin lesions aroun d the eye and 
neurological signs of infection were usually observed on 
day 5. The mice started to die on day 4 and the mortality 
rate peaked on day 6. There was also a second peak on day 
10 (Fig. 1 and 1A). The mortality rate decreased to zero 
after day 14. The total mortality rate of the mice was 
around 70 % during the acute phase of the viral infection. 
The sera of these mice were examined for HSV antibodies 
by the microneutralization method (Fig. 2). These antibodies 
first appeared in serum obtained on day 7. They rose 
rapidly on day 9 and day 10 and remained at a high level 
until day 54, the last day of these experiments. 
HSV was detected in the homogenates of · trigeminal 
ganglia (T G) and supe r i or cervical ganglia (SC G) during the 
acute phase of infection (Fig. 3 & 4). In t he TG homogenates, 
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viral infection could be demonstrated by day 2 after inoculation, 
reached a peak (100 %) on day 7 and fell rapidly thereafter. By 
day 10, HSV was no longer detected in the homogenates of TG. 
In the SCG homogenates, a similar result was obtained; however, 
HSV was demonstrated in a shorter period of time (Fig. 4). 
Using the explantation method, the presence of HSV in both 
ganglia was also readily detected during the acute phase of 
infection. Although the virus was detectable in TG on day 2 
by both homogenization and explantation methods, it was 
demonstrated in sec much earlier (day 2) by the explantation 
method than by the homogenization method (day 5). In both 
ganglia, there seems to be a higher i n cidence of viral 
detection by the explantation method than by the homogenization 
method (Fig. 3 & 4). After the acute phase of infection had 
subsided, the virus could not be demonstrated by the 
homogenization method. In contrast, the explantation method 
allowed the detection of virus in both ganglia during the 
la t ent phase of infection. Over 70 % of the ~G ganglion 
explants and around 20 % of the SCG ganglion explants demonstrated 
HSV latency. 
The titer of HSV in both infected ganglia was also 
measured during the acute phase of infection. As mentioned 
before, there was no detectable HSV in SCG before day 4 and 
after day 9 (Fig. 4). The viral titer measured in the SCG 
between day 5 and day 8 was from 10 to 10 4 PFU per ganglion 
(Fig. 5). Similarly, no HSV was detected in TG on day 1 and 
after day 10 (Fig. 6). The same titer, from 10 to 10 4 PFU 
per ganglion, was found between day 2 and day 9 in TG. 
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B. EVALUATIONS OF METHODS FOR REACTIVATIN G THE LATENT RSV INFECTION 
IN THE MOUSE MODEL 
1 . Trauma: 
In an attempt to reactivate the HSV, thermal or mechanical 
trauma was applied to the cornea of the latently infected 
mice. In two separate experiments, burning the cornea did 
not induce HSV reactivation in homogenates of both SCG and 
TG, although explants from the contralateral SCG and TG 
demonstrated viral latency (Table 1). Mechanical trauma was 
produced by brushing the cornea with a dental brush. The 
eye swabs were taken for two weeks after the mechanical trauma. 
Out of two separate experiments, only the righ t eye of one 
mouse (#7) showed viral reactivation (Fig. 7). Four days 
after brushing the cornea of this mouse, HSV was demonstrated 
to be present for five consecutive days. This may be a case 
of reactivation caused by the mechanical trauma; however, the 
possibility of spontaneous reactivation can not be ruled out. 
During the course of determining the best method of obtaining 
eye swabs from mice, we found that plain cotton swabs, both 
absorbent and non-absorbent, were more effective than commercially 
available calcium alginate swabs, especially for samples containing 
low viral concentrations. The results are graphically 
presented in Figure 8. 
2. Fever: 
As mentioned in Methods, mice were kept in a 37°c 
incubator and the rectal temperature was measured at different 
time intervals. The rectal temperature reached 1o4°F within 
3.5 hours and was maintained at .this temperature over a 
pe riod of 20 hours (Fig. 9). Eye swabs were taken daily. 
In twenty mice from two experiments, none of the eye showed 
any signs of virus reactivation (Fig. 10). 
The ganglia were then examined for evidence of reactiva-
tion undetectable by the eye swab method. HSV was not 
found in either the TG or SCG homogenate. However, with the 
explantation method, earlier ,CPE changes were observed in 
the fever-treated mice than in . the .no.n"-fever treated mice. 
3. Cyclophosphamide (CPA): 
The toxicity of intraperitoneally injected CPA at doses 
of 200mg, 300mg, 400mg and 500mg per kg body weight was tested 
using 10 mice in each of four different groups. Within the 
two week observation period, there were no deaths in the 
200mg/kg and 300 mg/kg CPA treated mice (Fig. 11). One mouse 
treated with CPA at 300mg;/kg died after two weeks (day t!5~. 
At higher doses, two mice in the 500mg/kg CPA group died before 
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day 9, whereas two mice in the 4oomg/kg CPA group died, one 
on day 8 and another on day 10. Thus, we used J00mg/kg 
CPA to treat the mice latently infected with HSV. At the 
same time, the right eye of each CPA treated mouse was 
burned in an attempt to enhance the reactivation. 
In the first experiment, no signs of reaction were 
observed in homogenates of ,b9th TG· and SCG from day 2 and 
da y 3 ( Table J). Howev er, t he left and right trigeminal 
ganglia from some of the CPA treated animals showed reactiva-
tion in specimens obtained on day 5. By contrast, the SCG 
from both sides in all CPA treated animals showed no signs 
of reactivation. In the second experiment, therefore, only 
the ganglia homogenates from day 5 were examined. Again, only 
th e trigeminal ganglia sho we d signs of reactiv~tion. 
In a third group of mice CPA was injected on day 0 and 
eye swabs were taken from day 1 t h rough · day 12. Three of 
twenty six eyes showed HSV reactivation during the period of 
the experiment , (Fig. 12). It should be mentioned that all 
HSV positi e s wabs came from those taken between day 1 and 
day 5. Thus, signs of HSV reactivation can be detected sooner 
by the eye swabs procedure than by ganglionic homogenates 
procedure. 
The mortality rate in the CPA treated mice was high 
during the experimental pe r iod. This wa s later shown to be 
due to bacterial infection and not to viral reactivation. 
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4 . UV-light irradiation: 
Ten latently infected mice were irradiated with a UV 
lamp for 24 hours on day O and for 2 hours daily in the 
following days (day 2 to day 14). Before each daily irradia-
tion procedures, eye swabs were taken from both le ft and 
right eyes for t wo weeks. None of the eye swabs sho wed any 
s igns of HSV reactivation (Fig. 1J). 
5. Stress: 
Physical stress was produced by suspending the mice by 
the front feet with their rear feet touching the surface of 
water in a pan placed underneath. Earlier experiments with 
this technique had shown that duodenal and gastric ulcers 
developed within 24 hours in one of four mice ~nd gastric 
perforations had developed within 48 hours in 2 out of 4 mice. 
Subsequently, 10 HSV latently infected mice were placed 
under identical physical stress for 24 hours. Daily eye 
swabs were taken from both left and ri gh t eyes for 2 weeks 
following the stress. There was no signs of HSV reactivation 
(Fig. 14). 
Results of these experiments are summerized in Table of 
next page. 
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HSV infection in the eye of CD-1 mice 
.. -- ... . _ ---
- . ... --· - -------. .. ··--· - ,._. .. -·---- -• - - -· ----- . - - . 
Acute Latent Recurrent Infection 
Thermal Mechanical Fever CPA Infection Infection trauma trauma 
E Vir us 100% 0% 1/72?* 1/36? o/4o 3/26 
y 
E Lesion ~100% 0% ND ND ND ND 
G 
A TG Homo 100% 0% 0/ 36 ND 0/22 5/20 
N 
G Exp 100% 70% 11/36 ND 5/22 ND 
L 
I Homo ~100% 0% 0/36 ND 0/22 0/20 
0 SCG 
N Exp 2'100 % 20% 8/36 ND 2/22 ND 
* By explantation of cornea. 
ND: Not done 
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0/20 o/14 
ND ND 
ND ND 
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ND ND 
ND ND 
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Fig. 1: The accumulated mortality rate during the acute phase of HSV infection 
(% of the accumulated number of dead mice on each day/total number of 
inoculated mice). Four seperate groups of mice ( indicated by A , o , <> 
V ) are included in this figure (there are 200, 70, 50 and 40 mice 
respectively in groups 1, 2, 3 and 4). 
Fig. 1A: The daily mortality rate during the acute phase of HSV infection 
(% of the number of dead mice on each day/total number of inoculated 
mice). The mean and standard deviations were calculated from the 
totals for the 4 different groups. (+: mean; +: S.D. ) 
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Fig. 2: The time course of HSV neutralizing antibody titers during acute 
phase of infection. 
o, The mean titer each day (n=6 before day 12 and n=3 :after day 12). 
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Fig. J: The percentage of HSV-positive trigeminal ganglia by explantation and 
homogenization method in mice following cornea inoculation (n=6 to 12). 
After cornea inoculation, animals were sacrificed each day. Each right 
ganglion was explanted in CV-1 cultures immediately after removal; 
the contralateral ganglion was homogenized and half of the homogenate 
was inoculated into CV-1 cultures. The homogenized cultures were examined 
daily for 15 days and the explant cultures for JO days for evidence of 
HSV CPE. 
p, The results from the explantation method. 
WlllJ, The results from the homogenization method. 
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Fig. 4: The percentage of HSV-positive superior cervical ganglia by explantation 
and homogenization method in mice following cornea inoculation (n=6 to 12). 
After cornea inoculation, animals were sacrificed each day. Each right 
ganglion was explanted in CV-1 cultures immediately after removal; 
the contralateral ganglion was homogenized and half of the homogenate 
was inoculated into CV-1 cultures. The homogenized cultures were 
examined daily for 15 days and the explant cultures for JO days for evidence 
of HSV CPE. 
D, The results from the explantation method. 
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D, The results from the homogenization method. 
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Fig. 5: The titer of HSV-positive superior cervical ganglia by the homogenzation 
method. 
After cornea inoculation, 6 animals were sacrificed each day. 
The left SCG was homogenized and half of the homogenated was 
quantitatively assayed for HSV titer by the plaquing method. 
+, The HSV titer in each SCG. 
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Fig. 6: The titer of RSV-positive trigeminal ganglia by the homogenzation 
method, 
After cornea inoculation, 6 animals were sacrificed each day. 
The left TG were homogenized and half of the homogenates was 
quantitatively assayed for HSV titer by the plaquing method. 
+, The HSV titer in each TG. 
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Fig. 7: Attempts at virus reactivation using mechanical 
trauma. Results of daily eye swab cultures. 
Experiment 1: The corneas were brushed twice on 
the day of stimulation. 
Experiment 2: The corneas were brushed eight times 
on the day · of stimulation. 
e, HSV positive eye swab cultures. 
o, HSV negative eye swab cultures. 
s, The day of mechanical trauma. 
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Fig. 8: Comparative sensitivity of absorbent and non-absorbent cotton swab 
versus calcium alginate swab for detection of HSV. 
A---~, Calcium alginate cotton swabs 
~---·-·+, Non-absorbent cotton swabs. 
o-----o, Absorbent cotton swabs. 
* Number of HSV positive swabs/total number of tested swabs. 
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Fig. 9: Time course of rectal temperature changes in mice during 37°c incubation. 
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Fig. 10: Attempts at virus reactivation using fever (104°F 
for 24 hours) as the stimulus. Results of the 
daily eye swab cultures. 
e, HSV positive eye swab cultures. 
o, HSV negative eye swab cultures. 
* Positive numbers represent days after fever 
stimulation and negative numbers represent 
days before fever stimulation. 
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Fig. 11: Toxicity of Cyclophosphamide (CPA) in CD-1 mice. 
e, Death of the first mouse. 
A, Death of the second mouse. 
* 10 mice in each CPA group (200 mg/kg, J00m g/kg, 4oomg/kg and 500mg/kg 
body weight) . 
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Fig. 12: Attempts of virus reactivation using an 
immunosuppressant, CPA. Results of daily eye swab 
cultures. 
e, HSV positive eye swab cultures. 
o, HSV negative eye swab cultures. 
M, . Mortality of mice. 
S, Cyclophosphamide treatment. 
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0 0 0 0 0 M 
0 0 • • • 
10 OD 0 0 0 OS 0 0 0 
11 OD 0 0 0 M OS 0 0 0 
12 OD 0 0 o . 0 0 0 0 0 0 0 0 M OS 0 0 0 0 0 0 0 0 0 0 0 
13 OD 0 0 0 0 0 0 0 0 0 0 0 0 OS 0 0 0 0 0 0 0 0 0 0 0 0 
0 1 2 3 4 6 7 8 9 10 11 12 
r~o. o f 1' 
~b e eye S Da s a f ter PA t reat men t 
(C A) 
87 
Fig. 1J: Attempts at viral reactivation using UV-light 
irradiation. Results of daily eye swab cultures. 
e, HSV positive eye swab cultures. 
o, HSV negative eye swab cultures. 
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Fig. 14: Attempts at virus reactivation using physical 
stress. Results of daily eye swab cultures. 
a, HSV positive eye swab cultures. 
o, HSV negative eye swab cultures. 
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Table 1: Attempts at HSV reactivation in TG and SCG by using therma1 -·injury 
on the cornea. 
* Control group. 
**, Number of HSV positive ganglia/total number of tested ganglia. 
(\J 
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Table 1t 
Method 
of 
assay 
Homogenization 
Explantation 
Tissue 
t es ted 
TG 
SCG 
TG 
SCG 
~Cornea 
Ex_Eeriment 1 
Days ~fter burning 
Day 2- Day _4 • Day 6 
Burn Cont ·· 
** 0/11 , 0/12 0/12 0/12 
0/12 0/12 0/12 0/12 
0/12 4/12 6/12 ,7/12 
2/12 5/12 J/11 1/12 
0/24 1/24 0/24 o/24 
Experiment 2 
Days after burning 
Day 2 _Q.~ 
·.Burn · Cont Burn Cont 
o/4 o/4 0/5 o/8 
0/5 0/5 o/6 0/J 
3/3 · J/J 
1/5 1/5 
(Y"\ 
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Table 2: Attempts at HSV reactivation in TG and SCG by using fever (104°F for 
24 hours) as the stumulus. 
*, Number of HSV positive ganglia/total number of tested ganglia. 
**, First day of appearance of CPE in CV-1 cells. 
_::j-
0'\ Tabl e 2: 
IVlethod 
of 
ass ~Y 
Homoginization 
Explantation 
Tissue 
tested 
SCG 
TG 
SCG 
TG 
Cornea 
Days after fever stimulation 
Control 
Day 1 Day 3 Day 5 
* o/s · o/s o/6 0/3 
o/s o/8 o/6 o/3 
o/8 o/8 · 2/6 1/6 (8,14) (12) 
1/8** 1/8 3/6 2/8 ( 7) (10) (7, ,7,14)" (15,25) 
0/16 ·0/16 0/12 I 0/16 
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Table J.: Attempts at HSV reactivation in TG and SCG by CPA and CPA plus corneal 
. 
burn (homogenization method) . 
* Experimental group: CPA treatment or CPA plus cornea burn at 
day O. 
** Control group: Saline injection at day O. 
➔~**, Number of HSV positive ganglia/total nu~ber of tested ganglia. 
'° 0\ Tab 1 ~ Jr 
Method 
of 
stimulation 
CPA 
alone 
CPA 
with burn 
rr1issue 
t--este ·d 
TG 
SCG 
TG 
SCG 
D 2 
* Exp Cont 
- -
- '-
0/5 o/4 
0/5 0/3 
Ex:eeriment 1 Experiment 2 
Days after CPA ·nays after CPA 
D J D. 5 
*'* Exp, Cont Exp C~:>nt· D 5 
I •** 0 7 - 1/5 ·- 1/6 
0/7 
·-
0/5 ·- 0/7 
- - 2/J 0/2 1/6 
- ·- 0/2 0/2 0/7 
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The three pha s es of HSV inf ection (acute, latent and 
recurr ent phases 1 were . demonstrable in our mou s e model. 
Afte r c orneal inoculation, both local and general signs of 
97 
HSV infection were observed. During the acute _phase of infec -
tion, not only was v iral multiplication in local ocular 
ti s sue demonstrated by cultures of eye swabbi ng s . bu ~ also 
a local immunoprotective mechanism (corneal cloud in e s s ) was 
seen under slitlainp examination ;, , -In -humans · .. and some 1 • 
laboratory animals, a localized corneal lesion .of HSV infec-
tion (dendritic, g eographic and disciform lesio n s) can be 
observed ( Kibrick and Laibson, 19 67; Nesburn et al, 1977). 
Howe v er, these typical lesions of HSV infection were n ot 
seen on the cornea of HSV infected CD-1 mice. Nevertheless , g en era l 
b e havioral and neurological s i gns of acute HSV infection which 
have b een described by others (Knotts et al, 1974; Scriba, 
1975; Hill et al, 1975) wer.e pr~sent. 
For the two week period o f acute infection, a mortality 
rate of approximately 70% was observed. There were two peaks 
in the daily mortality rate during this phase. It has been 
reported that the host-immune mechanism may play an important 
role in protecting the HSV infected animals, eve n though . the 
~atency .of HSV in ganglionic cell s could not be completely 
eliminated (Price et al, 19 75 ; Walz et al, 1975; Kline, 1980). 
In our studies, the drop followi n g the first peak of the daily 
mortality rate may be due to this protective mechanism. 
Gershon and Knodo (1971) have suggested that T-suppressor 
cells are induced as a part of feedback control mechanism 
during the T-dependent immune response. Thus, the rise 
of the second peak in our studies may be due to the increasing 
activity of the T-suppressor cells. 
Ganglionic infection with HSV in both trigeminal and 
superior cervical ganglia was demonstrated during the acute 
phase infection in our mice. HSV was recovered from almost 
100% of the homogenates and the explants of ganglia 7 days 
after corneal inoculation. During the acute phase, the 
explantation method seemed to be more sensitive than the 
homogenization method for detecting HSV within the ganglia, 
Following primary infection, HSV may become latent 
within the ganglia. We found, similar to r ·esults of other 
(Stevens and Cook, 1971; Hill et al, 1975), that infectious 
virus could not be demonstrated within the cell-free 
homogenates of the ganglia, but virus could be reactivated 
by the explantation method during the latent phase of infec-
tion. The incidence of occurence in trigeminal ganglia 
(above 75%) was much higher than that in superior cervical 
ganglia (approximately 12 %). Despite the fact that the 
explantation method could demonstrate the presence of HSV 
within the ganglion, it is still not a direct way to show 
that HSV is latent within the ganglia. Explantation may be 
just a method for demonstrating small amounts of infectious 
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viruses rather than a method for proving latency. Some 
tantalizing questions about HSV l~tency still remain 
unexplained. How are latent infections established and 
maintained? Howmahyganglia become latently infected following 
acute infections? 
In our studies, virus was never detected either in 
ganglionic homogena t es or in preocular tear films during 
the latent period. This suggests that spontaneous , reactiva-
tion is not common in the CD-1 mouse. Other investigators 
have also failed to demonstrate spontaneous reactivation in 
the mouse (Openshaw et al, 1979; Knotts, Cook and Stevens, 
1974). In contrast, apparent low gr.ade virus replication 
or frequent spontan~bus reactivation appears to occur in 
some mouse models (Hill et al, 197_8) and is common in rabbits 
(Laibson and Kibrick, 1969; Nesburn et al, 1977) and 
guinea pigs (Scriba, 1975). 
In an attempt to induce recurrent infection, different 
stimuli, such as fever, thermal burn, an - immunosuppressant 
agent, UV-light radiation, physical stress and mechanical 
trauma were applied to mice with latent infection. Only 
the immunosuppressant agent, cyclo9hosphamide (CPA) was able 
to induce a low grade reactivation (approximately 12 %) 
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in both cultures of eye swabs and homogenates of the trigeminal 
ganglia. A similar incidence of reactivation was observed 
in the skin and sensory ganglia of mice by Ophenshaw et al 
(1979) and in the skin of mice by Hough et al (1975). 
100 
In our studies using CPA to in du ce reactivation , HSV appeared 
in cultures of eye swa bs sooner than in ganglionic homogenates. 
Similar observations were made by Nesburn (1979) in rabbits. 
Nesburn explained the later appearance of the virus in 
ganglia as probably due to insufficient virus present in 
the neuronal veservoir at the time of reactivation. Another 
explanation of this discrepancy of timing may be rela te d to 
t he skin trigger theory (Hill and Blyth, 1976). Hill and 
Blyth suggested that virus may be consistantly presen t in 
the peripheral tissue (due to reactivation and release from 
the neural reservoir) but that it is controlled by t he immune 
mechanism during the latent phase of infection. Thus, 
once the immune control is removed by an immunosuppressant 
agent, as in our studies, the virus becomes reactive 
immedia t ely at the p e r ipheral tissue. In addition, if the 
round-trip hypothesis is true (Klein, 1976), virus from 
peripheral reactivated sites may be transported in retrograde 
fashion to the ganglia. Thus, the recovery of HSV virus 
within the ganglia may represent virus derived from peripheral 
sites. 
The rabbits' eye has also been used as a model for 
investigating HSV recurrent infection in our laboratory 
(Kibric k and Laibson, 1967). There are some differences 
between the infectious course in these two species: 1. During 
the acute phase and the recurrent phase of HSV infection in 
rabbits, typical dendritic corneal lesions usually accompany 
HSV positive cultures of eye swabs. These lesions were 
not observed on the cornea of the mouse either in acute or 
recurrent phase of infection. 2. In the rabbits' eye, 
spontaneous reacti v ations of HSV had been frequently 
observed by Laibson and Kibrick (1969) in their three-year 
longitudinal studies. For CD-1 mice, either no spontaneous 
reactivation or much less spontaneous reactivation was seen 
during the latent phase of HSV infection. 3. A high rate 
of HSV reactivation by stimuli, epinephrine ointment on 
t he eye or head X-ray radiation, had been induced in the 
rabbits by Kibrick and his associates (1969, 1970). In the 
mouse eyes, only low grade, or no, reactivation of HSV infec-
tion was induced by a variety of stimuli that we test ed. 
These differences may be due to the species difference 
between the mouse and the rabbit. 
During the course of determining the best method to 
obtain eye swabbing in mice, we found that plain cotton 
swabs were more sensitive than commercially available calcium 
alginate swabs. The calcium alginate has been reported to 
bind directly to HSV virion, rendering it non~infectious 
(Crane et al, 1980). Thus, some clinical reports in which 
calcium alginate swabs were utilized be re-examined (Reeves 
et al, 1981). 
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F ig. Color 1: Nor mal CD-1 mouse, 4 weeks old. 
Fi g . Colr 2: CD-1 mouse with acute HSV infection 
(7 days after cornea inoculation). 
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Fig , Color J: CD-1 mouse with latent HSV infection 
(one month after cornea inoculation). 
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Fig. Color 4: Flask cul t ures containing CV-1 cells. 
Fig. Color 5: Inverted microscop. 
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Fig. Color 6 : CV-1 culture tubes in the 37°c incubator. 
Fig. Color 7: CV-1 culture tubes in the rack ,. 
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Fig. Color 8: ACCU-LITE. 
Fig. Color 9: HSV plaques on the 60 mm on tissue culture 
dishes. 
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Fig. Color 10: A typical HSV plaque focus (20 X). 
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Fig. Color 11: Normal CV-1 ce -11s (50 X). 
Fig. Color 12: Normal CV-1 cells (100 X). 

123 
Fig. Color 1J: Typical CPE; HSV infected CV-1 cell . cultures: 
Refractile round cells (50X). 
Fig. Color 14: Typical CPE; HSV infected CV-1 cell cultures: 
Refractile round cells (100 X ). 
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Fig. Color 15: Typical CPE; HSV infected CV-1 cell culture: 
showing Syncytia (50 X). 
Fig. Color 16: Typical CPE; HSV infected CV-1 cell culture: 
showing Syncytia (100 X). 

125 
Fig. Color 17: The terminal stage of CPE; HSV infected 
CV-1 cell culture. 

